MEN1 and gastrin-producing neuroendocrine tumor: Considering the young average age of diagnosis of MEN1–ZES (around 40 years), one might argue that an overall survival of 15–20 years results in a substantial number of patients with MEN1 and gastrinomas dying before the age of 60.